• The RayPilot solution

    Enables Hypofractionated Accurate RadioTherapy (HART)

Home / Healthcare professionals

RayPilot offers accurate localization and tracking of prostate motion

Micropos Medical provide advanced technologies, powered by Artificial Intelligence (AI),  with potential to enhance the accuracy in radiotherapy of cancer. RayPilot HypoCath, including a patented temporary transmitter, tracks the prostate tumor movements and outlines urethra  in real time in 3D. This can facilitate hypofractionated radiation therapy when physicians reduce treatment margins to a minimum (sparing healthy tissue) while increasing the dose to the tumor (less number of fractions), for a more efficient outcome. All in all to optimize the treatment.


Extra bolagstämma i Micropos Medical

Kallelse till extra bolagsstämma i Micropos Medical AB (publ) Aktieägarna i Micropos Medical AB (publ) (”Bolaget”), 556648-2310, kallas härmed till extra bolagsstämma tisdag den 12…

Read more

Clinical data from RayPilot® System use

We are very pleased to see these preliminary data from the use of the RayPilot® System for SBRT for prostate cancer patients, published in the…

Read more
See all news